Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

897 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T. Okazawa M, et al. Among authors: suzuki o. Int J Gynecol Cancer. 2013 Mar;23(3):567-75. doi: 10.1097/IGC.0b013e31828703fd. Int J Gynecol Cancer. 2013. PMID: 23385284
Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters.
Isohashi F, Mabuchi S, Yoshioka Y, Seo Y, Suzuki O, Tamari K, Yamashita M, Unno H, Kinose Y, Kozasa K, Sumida I, Otani Y, Kimura T, Ogawa K. Isohashi F, et al. Among authors: suzuki o. Radiat Oncol. 2015 Aug 25;10:180. doi: 10.1186/s13014-015-0486-5. Radiat Oncol. 2015. PMID: 26300325 Free PMC article.
Dose-volume analysis of predictors for chronic gastrointestinal complications in patients with cervical cancer treated with postoperative concurrent chemotherapy and whole-pelvic radiation therapy.
Isohashi F, Mabuchi S, Akino Y, Yoshioka Y, Seo Y, Suzuki O, Tamari K, Yoshino K, Sawada K, Ueda Y, Kobayashi E, Sumida I, Mizuno H, Okubo H, Kimura T, Ogawa K. Isohashi F, et al. Among authors: suzuki o. J Radiat Res. 2016 Nov;57(6):668-676. doi: 10.1093/jrr/rrw037. Epub 2016 Jun 24. J Radiat Res. 2016. PMID: 27342839 Free PMC article.
Definitive radiotherapy for primary vaginal cancer: correlation between treatment patterns and recurrence rate.
Kanayama N, Isohashi F, Yoshioka Y, Baek S, Chatani M, Kotsuma T, Tanaka E, Yoshida K, Seo Y, Suzuki O, Mabuchi S, Shiki Y, Tatsumi K, Kimura T, Teshima T, Ogawa K. Kanayama N, et al. Among authors: suzuki o. J Radiat Res. 2015 Mar;56(2):346-53. doi: 10.1093/jrr/rru115. Epub 2015 Jan 22. J Radiat Res. 2015. PMID: 25614068 Free PMC article. Clinical Trial.
897 results